|
FAM104A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.06519999995858E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.212300E-04 |
| Normal-vs-Stage2 |
1.503600E-03 |
| Normal-vs-Stage3 |
8.16430000000201E-05 |
| Normal-vs-Stage4 |
2.335700E-02 |
| Stage1-vs-Stage2 |
4.679600E-01 |
| Stage1-vs-Stage3 |
4.613700E-02 |
| Stage1-vs-Stage4 |
9.972400E-02 |
| Stage2-vs-Stage3 |
3.025000E-01 |
| Stage2-vs-Stage4 |
1.542950E-01 |
| Stage3-vs-Stage4 |
3.073400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.13530000001028E-06 |
| Normal-vs-AfricanAmerican |
1.956710E-04 |
| Normal-vs-Asian |
2.28400000001905E-06 |
| Caucasian-vs-AfricanAmerican |
6.496400E-01 |
| Caucasian-vs-Asian |
2.744300E-02 |
| AfricanAmerican-vs-Asian |
4.576300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88490999999402E-05 |
| Normal-vs-Female |
1.56489999847409E-08 |
| Male-vs-Female |
2.855100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.457900E-03 |
| Normal-vs-Extreme_Weight |
4.829700E-04 |
| Normal-vs-Obese |
1.96252999999924E-05 |
| Normal-vs-Extreme_Obese |
3.082400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.867200E-01 |
| Normal_Weight-vs-Obese |
9.278000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.957000E-01 |
| Extreme_Weight-vs-Obese |
3.172000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.505200E-01 |
| Obese-vs-Extreme_Obese |
5.159200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.89909998627292E-09 |
| Normal-vs-Age(41-60Yrs) |
8.82899997556308E-09 |
| Normal-vs-Age(61-80Yrs) |
4.239300E-04 |
| Normal-vs-Age(81-100Yrs) |
9.225400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.700900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.00610000000001E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.83030000000218E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.463780E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.199170E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.781600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.23040000002506E-06 |
| Normal-VS-Type2 PRCC |
5.822700E-03 |
| Normal-VS-KIRP CIMP |
6.39439999999825E-05 |
| Normal-VS-Unclassified PRCC |
5.642300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.284400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.047500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.789600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.60279999994462E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.658200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.84439999999908E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.096600E-03 |
| Normal-vs-N1 |
8.19390000000864E-05 |
| Normal-vs-N2 |
1.643010E-01 |
| N0-vs-N1 |
7.560000E-03 |
| N0-vs-N2 |
2.749600E-01 |
| N1-vs-N2 |
5.530200E-01 |
|
|
